MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Physical Therapy and Deep Brain Stimulation in Parkinson Disease: A Pilot Randomized Controlled Trial

R. Duncan, K. Rawson, G. Earhart, L. Van Dillen, J. Perlmutter (Saint Louis, MO, USA)

Meeting: MDS Virtual Congress 2020

Abstract Number: 1191

Keywords: Deep brain stimulation (DBS), Gait disorders: Treatment, Rehabilitation

Category: Physical Therapy, Speech Therapy, Rehabilitation

Objective: To determine the safety, feasibility, and preliminary efficacy of physical therapy (PT) for people with Parkinson disease (PD) who have deep brain stimulation (DBS).

Background: DBS in people with PD provides inconsistent benefit for postural instability and gait difficulty. PT may be a useful intervention for improving postural stability and gait in people with DBS. However, the safety, feasibility, and preliminary efficacy of PT for people with PD with DBS remains unknown. We hypothesized that PT would be safe, feasible, and effective in improving postural stability and gait in this population.

Method: Twenty-nine participants (mean age: 64.9 ± 6.9; 72% male; mean MDS-UPDRS III: 33.2 ± 11.4) with PD and at least one year after subthalamic nucleus (STN) DBS were randomly assigned to either PT or no intervention. Those receiving PT (n=15) attended one-hour sessions twice weekly for eight weeks. The PT included exercises focused on improving postural stability and gait. Those assigned to no intervention (n=14) went about their daily lives as usual. Safety was measured by collecting information related to adverse events during the intervention sessions. Feasibility was measured as the percentage of sessions attended out of the total possible number of sessions. Efficacy measures were collected at pre- and post-intervention. Postural stability was measured using the Balance Evaluation Systems Test (BESTest). Gait velocity was measured using the GAITRite instrumented mat. Repeated measures ANOVAs with group and time as factors were utilized to determine the presence of main effects of group and time and group x time interactions (α=.05). Age was included as a covariate in the model because it differed between groups at baseline.

Results: Physical therapy was safe as there were no serious adverse events during the intervention sessions. Physical therapy was feasible as participants attended on average 93% of sessions (range: 81-100%). After controlling for age, there were group x time interactions for postural stability (F=5.86; p=.023) and gait (F=4.64; p=.041) with the PT group demonstrating improvement while the control group did not change.

Conclusion: Physical therapy is safe, feasible, and may be effective for improving postural stability and gait among people living with PD and STN-DBS. Our results suggest further study of the efficacy of physical therapy for this population is warranted.

To cite this abstract in AMA style:

R. Duncan, K. Rawson, G. Earhart, L. Van Dillen, J. Perlmutter. Physical Therapy and Deep Brain Stimulation in Parkinson Disease: A Pilot Randomized Controlled Trial [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/physical-therapy-and-deep-brain-stimulation-in-parkinson-disease-a-pilot-randomized-controlled-trial/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/physical-therapy-and-deep-brain-stimulation-in-parkinson-disease-a-pilot-randomized-controlled-trial/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley